Enhancement of vascular action of arginine vasopressin by diminished extracellular sodium concentration (Q42503481)

1 November 2017

Enhancement of vascular action of arginine vasopressin by diminished extracellular sodium concentration (English)

1 reference

1 November 2017

0 references

Robert William Schrier

5

object named as

Schrier RW

1 reference

1 November 2017

Okada K

1

1 reference

1 November 2017

Ishikawa S

2

1 reference

1 November 2017

Caramelo C

3

1 reference

1 November 2017

Tsai P

4

1 reference

1 November 2017

language of work or name

English

0 references

publication date

1 October 1993

1 reference

1 November 2017

1 reference

1 November 2017

44

1 reference

1 November 2017

4

1 reference

1 November 2017

755-763

1 reference

https://scigraph.springernature.com/pub.10.1038/ki.1993.310

1 November 2017

0 references

cites work

Radioimmunoassay of plasma arginine vasopressin in hyponatremic patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.310

7 January 2021

Acute hemodynamic effect of a vascular antagonist of vasopressin in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.310

7 January 2021

Vasoconstrictor role for vasopressin in experimental heart failure in the rabbit

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.310

7 January 2021

Role of vasopressin in abnormal water excretion in cirrhotic patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.310

7 January 2021

Disturbed volume homeostasis in patients with cirrhosis of the liver

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.310

7 January 2021

Importance of sodium intake and mineralocorticoid hormone in the impaired water excretion in adrenal insufficiency

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.310

7 January 2021

Effect of arginine vasopressin antagonist on renal water excretion in glucocorticoid and mineralocorticoid deficient rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.310

7 January 2021

Role of plasma vasopressin in impaired water excretion of glucocorticoid deficiency

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.310

7 January 2021

Role of vasopressin in the impaired water excretion of glucocorticoid deficiency

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.310

7 January 2021

The role of vasopressin in the impaired water excretion of myxedema

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.310

7 January 2021

Vascular effects of arginine vasopressin during fluid deprivation in the rat.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.310

7 January 2021

Pathogenesis of sodium and water retention in high-output and low-output cardiac failure, nephrotic syndrome, cirrhosis, and pregnancy (1)

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.310

7 January 2021

Body fluid volume regulation in health and disease: a unifying hypothesis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.310

7 January 2021

Na+-Ca2+ exchange in cultured vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.310

7 January 2021

Effect of inhibition of Na+/K(+)-adenosine triphosphatase on vascular action of vasopressin

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.310

7 January 2021

Leukotriene C4 and D4 contract rat glomerular mesangial cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.310

7 January 2021

Prompt inhibition of arginine vasopressin-induced cellular adenosine 3',5'-monophosphate production by extracellular sodium depletion in rat renal inner medullary collecting duct cells in culture

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.310

7 January 2021

Mechanism of cellular effect of phorbol esters on action of arginine vasopressin and angiotensin II on rat vascular smooth muscle cells in culture

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.310

7 January 2021

Effect of a new V1 antagonist (OPC-21268) on vascular action of vasopressin in cultured rat vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.310

7 January 2021

Multiple Signaling Pathways of V1-Vascular Vasopressin Receptors of A75rCells*

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.310

7 January 2021

The calcium messenger system (1).

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.310

7 January 2021

The calcium messenger system (2).

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.310

7 January 2021

The regulation of the cytoplasmic free Ca2+ concentration in aortic smooth muscle cells (A7r5 line) after stimulation by vasopressin and bombesin

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.310

7 January 2021

The role of protein kinase C in cell surface signal transduction and tumour promotion

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.310

7 January 2021

Phorbol ester effects on neurotransmission: interaction with neurotransmitters and calcium in smooth muscle

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.310

7 January 2021

Activation of tracheal smooth muscle contraction: synergism between Ca2+ and activators of protein kinase C

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.310

7 January 2021

Contraction of rat thoracic aorta strips induced by phorbol 12-myristate 13-acetate

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.310

7 January 2021

Phorbol 12,13-dibutyrate-induced contraction of isolated rabbit vascular smooth muscle

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.310

7 January 2021

Identifiers

DOI

10.1038/KI.1993.310

1 reference

1 November 2017

1 reference